相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long-term tumour dormancy in a BRCA1 heterozygote
Setor Amuzu et al.
JOURNAL OF MEDICAL GENETICS (2023)
Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing
Isidro Cortes-Ciriano et al.
NATURE GENETICS (2020)
Narrative review on serous primary peritoneal carcinoma of unknown primary site: four questions to be answered
Elie Rassy et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
Retrospective study of a 16 year cohort of BRCA1 and BRCA2 carriers presenting for RRSO: Prevalence of invasive and in-situ carcinoma, with follow-up
F. Blok et al.
GYNECOLOGIC ONCOLOGY (2019)
Development of Peritoneal Carcinoma in women diagnosed with Serous Tubal Intraepithelial Carcinoma (STIC) following Risk-Reducing Salpingo-Oophorectomy (RRSO)
P. I. Stanciu et al.
JOURNAL OF OVARIAN RESEARCH (2019)
Genomic landscape and evolutionary trajectories of ovarian cancer precursor lesions
Ren-Chin Wu et al.
JOURNAL OF PATHOLOGY (2019)
Ovarian carcinomas: at least five different diseases with distinct histological features and molecular genetics
Jaime Prat et al.
HUMAN PATHOLOGY (2018)
Evidence for lineage continuity between early serous proliferations (ESPs) in the Fallopian tube and disseminated high-grade serous carcinomas
Thing Rinda Soong et al.
JOURNAL OF PATHOLOGY (2018)
Defective DNA damage repair leads to frequent catastrophic genomic events in murine and human tumors
Manasi Ratnaparkhe et al.
NATURE COMMUNICATIONS (2018)
High grade serous ovarian carcinomas originate in the fallopian tube
S. Intidhar Labidi-Galy et al.
NATURE COMMUNICATIONS (2017)
Serous tubal intraepithelial carcinomas associated with high-grade serous ovarian carcinomas: a systematic review
F. Chen et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2017)
Molecular Alterations of TP53 are a Defining Feature of Ovarian High-Grade Serous Carcinoma: A Rereview of Cases Lacking TP53 Mutations in The Cancer Genome Atlas Ovarian Study
Russell Vang et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2016)
Epithelialization of mouse ovarian tumor cells originating in the fallopian tube stroma
Yuanyuan Hua et al.
ONCOTARGET (2016)
Clinical outcomes in patients with isolated serous tubal intraepithelial carcinoma (STIC): A comprehensive review
Maria Guadalupe Patrono et al.
GYNECOLOGIC ONCOLOGY (2015)
Serous Tubal Intraepithelial Carcinoma (STIC)-like Lesions Arising in Ovarian Serous Cystadenofibroma: Report of 2 Cases
Elaine Craig et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2015)
Ovarian Cancer Risk After Salpingectomy: A Nationwide Population-Based Study
Henrik Falconer et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Whole-genome characterization of chemoresistant ovarian cancer
Ann-Marie Patch et al.
NATURE (2015)
Ovarian Cancer Risk After Salpingectomy: A Nationwide Population-Based Study
Henrik Falconer et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Origin and Pathogenesis of Pelvic (Ovarian, Tubal, and Primary Peritoneal) Serous Carcinoma
Niloofar N. Nik et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 9 (2014)
Outcome of unexpected adnexal neoplasia discovered during risk reduction salpingo-oophorectomy in women with germ-line BRCA1 or BRCA2 mutations
James R. Conner et al.
GYNECOLOGIC ONCOLOGY (2014)
Retinoblastoma pathway deregulatory mechanisms determine clinical outcome in high-grade serous ovarian carcinoma
Anca Milea et al.
MODERN PATHOLOGY (2014)
Ovarian Cancer Rates After Hysterectomy With and Without Salpingo-Oophorectomy
John K. Chan et al.
OBSTETRICS AND GYNECOLOGY (2014)
The Race to Clone BRCA1
Mary-Claire King
SCIENCE (2014)
Criteria for Inference of Chromothripsis in Cancer Genomes
Jan O. Korbel et al.
CELL (2013)
Long term follow up of BRCA1 and BRCA2 mutation carriers with unsuspected neoplasia identified at risk reducing salpingo-oophorectomy
C. B. Powell et al.
GYNECOLOGIC ONCOLOGY (2013)
Genome Sequencing of Pediatric Medulloblastoma Links Catastrophic DNA Rearrangements with TP53 Mutations
Tobias Rausch et al.
CELL (2012)
Validation of an Algorithm for the Diagnosis of Serous Tubal Intraepithelial Carcinoma
Russell Vang et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2012)
TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma-evidence supporting the clonal relationship of the two lesions
Elisabetta Kuhn et al.
JOURNAL OF PATHOLOGY (2012)
High-grade serous ovarian cancer arises from fallopian tube in a mouse model
Jaeyeon Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Primary peritoneal high-grade serous carcinoma is very likely metastatic from serous tubal intraepithelial carcinoma: Assessing the new paradigm of ovarian and pelvic serous carcinogenesis and its implications for screening for ovarian cancer
Jeffrey D. Seidman et al.
GYNECOLOGIC ONCOLOGY (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
Development of the genital ducts and external genitalia in the early human embryo
Yasmin Sajjad
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2010)
Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary
Ashour Ahmed Ahmed et al.
JOURNAL OF PATHOLOGY (2010)
Genetic Analysis of the Early Natural History of Epithelial Ovarian Carcinoma
Bhavana Pothuri et al.
PLOS ONE (2010)
Increased p16 Expression in High-grade Serous and Undifferentiated Carcinoma Compared With Other Morphologic Types of Ovarian Carcinoma
V. Phillips et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2009)
Evidence for a latent precursor (p53 signature) that may precede serous endometrial intraepithelial carcinoma
Elke A. Jarboe et al.
MODERN PATHOLOGY (2009)
The Preclinical Natural History of Serous Ovarian Cancer: Defining the Target for Early Detection
Patrick O. Brown et al.
PLOS MEDICINE (2009)
A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations
Ann K. Folkins et al.
GYNECOLOGIC ONCOLOGY (2008)
The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome
F Medeiros et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2006)
Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers
A Finch et al.
GYNECOLOGIC ONCOLOGY (2006)
BRCA-mutation-associated fallopian tube carcinoma - A distinct clinical phenotype?
R Cass et al.
OBSTETRICS AND GYNECOLOGY (2005)
Cancer of the ovary
SA Cannistra
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Colorectal adenomas: A prototype for the use of surrogate end points in the development of cancer prevention drugs
GJ Kelloff et al.
CLINICAL CANCER RESEARCH (2004)
Prophylactic oophorectomy - A morphologic and immunohistochemical study
PW Schlosshauer et al.
CANCER (2003)
Pathologic findings in prophylactic oophorectomy specimens in high-risk women
K Leeper et al.
GYNECOLOGIC ONCOLOGY (2002)
Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer
JMJ Piek et al.
JOURNAL OF PATHOLOGY (2001)
Molecular evidence linking primary cancer of the Fallopian tube to BRCA1 germline mutations
RP Zweemer et al.
GYNECOLOGIC ONCOLOGY (2000)
分享论文
